Homepage | Lupus Science & Medicine
Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …
Clinical trial outcomes for SLE: what we have and what we need
The paradigm of drug approval in SLE currently relies on successful large phase III randomised controlled trials and a set of primary, secondary and additional end points. Taken together, …
About | Lupus Science & Medicine
Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …
Effects of systemic lupus erythematosus on the brain: a systematic ...
Background Cognitive dysfunction (CD) is highly prevalent in systemic lupus erythematosus (SLE), yet the underlying mechanisms are poorly understood. Neuroimaging utilising …
Scoring systemic lupus erythematosus (SLE) disease activity with …
Introduction. SLE is a heterogeneous, multisystem autoimmune disease characterised by waxing and waning disease activity over time.1 Accurately measuring lupus disease activity and the …
Cutaneous vasculitis in SLE | Lupus Science & Medicine
Cutaneous vasculitis was observed in 17.3% of patients with SLE. The mean time to cutaneous vasculitis after SLE diagnosis was 4.78 years (95% CI 3.96 to 5.60). Among patients who …
Thanoua etΔal Lupus Science Medicine 216e365 doi11136lupus21365 1 Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures Aikaterini Thanou , …
Systemic lupus erythematosus and neutropaenia: a hallmark of ...
Objective Systemic lupus is a chronic autoimmune disease characterised by its phenotypic heterogeneity. Neutropaenia is a frequent event in SLE occurring in 20%–40% of patients …
Authors | Lupus Science & Medicine - Lupus Science & …
35 days (median) Acceptance rate: 33%. Impact factor: 3.7. Lupus Science & Medicine® is a global, peer reviewed, open access, online journal that provides a central point for publication …
Current and future therapies for SLE: obstacles and …
Currently available treatments. Organ involvement and its related disease activity dictate the treatment for SLE. For constitutional symptoms and mild-to-moderate SLE, current guidelines …